India Tissue Diagnostics Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

India Tissue Diagnostics Market Overview

Tissue diagnostics is gaining significant importance as healthcare providers increasingly focus on accurate disease identification and improved clinical outcomes through advanced diagnostic technologies. The market is poised to grow at a CAGR of 9.10% during the forecast period of 2026-2035, due to greater awareness of early diagnosis and increasing investments in pathology laboratories. The growing cancer burden, improving diagnostic infrastructure, and rising healthcare expenditure are also driving the market growth.

India Tissue Diagnostics Market Growth Analysis and Key Influencers

India Tissue Diagnostics Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

India Tissue Diagnostics Market Growth Drivers

Rapid Molecular Diagnostics and Precision Oncology Advancements to Enhance Market Landscape

The increasing adoption of advanced molecular diagnostic technologies is driving the expansion of tissue diagnostics by enabling faster and more accurate cancer detection. For instance, in June 2026, Agilus Diagnostics launched the automated Idylla molecular diagnostics system at its Goregaon laboratory in Mumbai, allowing detection of cancer-related genetic mutations within 2.5 to 3 hours. The system supports the identification of biomarkers such as EGFR, KRAS, NRAS, and BRAF, improving precision oncology decision-making. Because the platform can support testing when tissue samples are limited, such developments can complement tissue-based diagnostic workflows and strengthen precision oncology capabilities. Such innovations are expected to strengthen diagnostic capabilities and accelerate market growth.

India Tissue Diagnostics Market Restraints

High Cost of Biopsy Procedures Limits Market Expansion

The high cost associated with biopsy procedures and advanced tissue diagnostic testing remains a key challenge affecting accessibility and adoption. According to DivinHeal, the cost of biopsy tests in India varies significantly, ranging from approximately INR 1,500 to INR 30,000 depending on the procedure type, technology used, and healthcare facility. This financial burden can delay diagnosis, particularly among price-sensitive patient populations. As a result, affordability concerns and uneven access to advanced diagnostic facilities may restrict wider adoption of tissue diagnostics across the country.

India Tissue Diagnostics Market Opportunities

Expansion of Cancer Genomics and Personalized Diagnostics Creates Growth Potential

The growing focus on cancer genomics and personalized medicine is creating new avenues for tissue diagnostics through improved biomarker identification and targeted treatment approaches. For instance, in February 2026, the Indian Institute of Technology Madras released the Bharat Cancer Genome Atlas, a genome database covering pediatric leukemia, colorectal, and pancreatic cancers, supported by Hyundai Motor India’s Hyundai Hope for Cancer initiative. The database aims to identify cancer-specific biomarkers and improve early detection and treatment strategies. Its biomarker and genomic research applications can support the broader precision-diagnostics ecosystem.

India Tissue Diagnostics Market Trends

Some of the notable trends in the market are automation integration, molecular diagnostics advancement, and precision oncology adoption.

Rising Adoption of Laboratory Automation Technologies is Expected to Enhance Market Growth

The increasing use of automated laboratory solutions is transforming tissue diagnostics by reducing manual errors, improving turnaround time, and supporting high-volume testing requirements. For instance, in May 2026, Tecan established direct sales and specialist laboratory automation service operations in India, including a dedicated local team in Gurugram, to support pharmaceutical, biotechnology, academic, and diagnostic sectors. The expansion strengthens India's laboratory automation infrastructure, which can support the modernization and efficiency of diagnostic laboratories, including facilities involved in tissue diagnostics. Such advancements in automation infrastructure are expected to improve diagnostic efficiency and contribute to market growth.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

India Tissue Diagnostics Market Share

Breast Cancer Diagnostics Segment is Likely to Lead Market by Application

The market is segmented based on application into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and others. Among these applications, breast cancer diagnostics are expected to hold a leading position due to the rising disease burden and increasing demand for early detection and personalized treatment approaches. According to Vaitheeswaran Kulothungan et al., 2024, female breast cancer was the leading cause of cancer incidence and mortality in India, accounting for 13.5% of new cancer cases and 10% of cancer-related deaths in 2020. The growing need for accurate tissue-based diagnosis and biomarker testing for breast cancer management is expected to support segment expansion and overall market growth.

Leading Players in the India Tissue Diagnostics Market

India Tissue Diagnostics Market Segmentation

Key Questions Answered in the India Tissue Diagnostics Market Report

• What was the India tissue diagnostics market value in 2025?
• What is the India tissue diagnostics market forecast outlook for 2026-2035?
• What are the major factors aiding the India tissue diagnostics market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major India tissue diagnostics market trends?
• Which product and services is expected to dominate the market segment?
• Which technology is projected to lead the market segment?
• Which application is anticipated to drive the market segment?
• Which end user is likely to dominate the market segment?
• Who are the key players involved in the India tissue diagnostics market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a comprehensive mixed-methods research approach combining:

• Primary Research: In-depth interviews and discussions with 30+ pathology experts, oncologists, laboratory managers, diagnostic service providers, procurement professionals, and industry stakeholders across India to understand market trends, adoption patterns, and technology advancements.
• Secondary Research: Analysis of peer-reviewed publications from journals such as The Lancet Oncology, Indian Journal of Pathology and Microbiology, and Journal of Clinical Pathology; regulatory information from the Indian Council of Medical Research (ICMR), National Accreditation Board for Testing and Calibration Laboratories (NABL), and CDSCO; clinical and epidemiological data from WHO, Global Cancer Observatory, and government healthcare reports; along with key insights from company websites and product portfolios.
• Validation: Market estimates are validated through top-down and bottom-up approaches, data triangulation, and expert feedback to ensure accuracy and reliability.